Press Release Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 Jul 9
Press Release Organogenesis Announces FDA Acceptance of Biologics License Application for ReNuĀ® for the Management of Symptomatic Knee Osteoarthritis Jul 6